Project Grant HT94252410758
Award Date 7/15/24
Completion Date 7/14/27
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
South Miami, FL 33146, USA
Similar Awards
- The U.S. Defense Health Agency awarded a $737,500 Project Grant to Florida International University (FIU) under the Military Medical Research and Development program (CFDA 12.420) to develop a novel treatment for spinal cord injury-neuropathic pain by targeting fibroblast-derived PI16. The award has a performance period from May 15, 2025 to May 14, 2028. FIU, a Hispanic-Serving Institution and one of the largest minority-serving research universities in the U.S., will leverage its diverse...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
- The University of Miami was awarded a $2,070,414 Project Grant by the U.S. Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant, effective May 1, 2025 through April 30, 2028, will fund research on mesenchymal stem cell extracellular vesicle therapies for epidermolysis bullosa, a rare genetic skin disorder. The research aims to develop innovative medical solutions to transform healthcare for military service members, veterans,...
- The University of Miami's Office of Research Administration - School of Medicine Division received a $1,871,460.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MECHANISMS AND UTILITY OF MULTISENSORY BODY REPRESENTATION IN SCI AND SCI-RELATED NEUROPATHIC PAIN". The grant, with a performance period from Sep 1, 2023 to Aug 31, 2026, will fund research into the mechanisms and applications of...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $301,000.00 to the University of Miami to develop an eHealth psychosocial stress and symptom management intervention for patients with pancreatic cancer. The project aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and management....
- The University of Miami was awarded a $1,534,998 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from August 15, 2023 to August 14, 2026, will fund research on the role of diffuse large B-cell lymphoma genome complexity in shaping immune responses to anti-CD19 chimeric antigen receptor T-cell therapies. As a non-profit educational institution and experienced federal grant recipient, the University of...
- The University of Miami received a $153,500 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENGINEERING TARGETED EXOSOME-BASED THERAPEUTICS FOR REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS IN TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER". The 2-year award period runs from February 15, 2024 to February 14, 2026. The Project Grant supports the university's work to develop novel...
- This Project Grant award of $894,330.00 from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding research conducted by the University of Miami to investigate "Targeting Axonal Regeneration Pathways as a Therapeutic Approach to ALS." The project aims to transform healthcare for military service members and the broader public by advancing biomedical research into innovative medical solutions for critical health challenges. The award...
- This $1,347,118 Project Grant was awarded on May 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research conducted by the University of Miami to target KIF20A, a kinesin with a novel, non-canonical role in castration-resistant prostate cancer. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research investigating medical...
- The University of Miami has been awarded a $1,700,000.00 Project Grant from the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research funded under this 2-year grant, with a performance period from September 15, 2024 to September 14, 2026, will explore innovative...